You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/111707
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGiannasi, Lilian Chrystiane-
dc.contributor.authorAlmeida, Fernanda Ribeiro-
dc.contributor.authorNacif, Sergio Roberto-
dc.contributor.authorFranco de Oliveira, Luis Vicente-
dc.date.accessioned2014-12-03T13:08:55Z-
dc.date.accessioned2016-10-25T20:09:32Z-
dc.date.available2014-12-03T13:08:55Z-
dc.date.available2016-10-25T20:09:32Z-
dc.date.issued2013-07-01-
dc.identifierhttp://dx.doi.org/10.11607/ijp.3284-
dc.identifier.citationInternational Journal Of Prosthodontics. Hanover Park: Quintessence Publishing Co Inc, v. 26, n. 4, p. 334-339, 2013.-
dc.identifier.issn0893-2174-
dc.identifier.urihttp://hdl.handle.net/11449/111707-
dc.identifier.urihttp://acervodigital.unesp.br/handle/11449/111707-
dc.description.abstractPurpose: The aim of this study was to validate the use of a mandibular repositioner appliance (MRA) to treat obstructive sleep apnea (OSA) and primary snoring, comparing polysomnographic and Epworth Sleepiness Scale (ESS) data obtained prior to and during MRA treatment. Materials and Methods: Sixty-three patients who presented with different degrees of OSA severity or primary snoring were fitted to a PM positioner between 2009 and 2011. The diagnosis was established by a polysomnogram (PSG) prior to treatment and after 6 months to verify the efficacy of MRA therapy. Subjective daytime sleepiness was evaluated by ESS questionnaire prior to treatment and at the follow-up. Results: Patients were divided into primary snoring and OSA groups. For the primary snoring group, PSG variables did not show significant results, except for a decrease in snoring. For the OSA group, the mean apnea-hypopnea index (AHI) was reduced from 23.0 +/- 11 to 5.3 +/- 4.0 and median ESS reduced significantly from 13.0 to 8.5. Complete response (AHI < 5) was found in 25 (40%) patients and partial response (AHI <= 10) in 27 (43%) patients. Conclusion: The findings validate the efficacy of the adjustable PM positioner for the safe treatment of OSA.en
dc.format.extent334-339-
dc.language.isoeng-
dc.publisherQuintessence Publishing Co Inc-
dc.sourceWeb of Science-
dc.titleEfficacy of an Oral Appliance for the Treatment of Obstructive Sleep Apneaen
dc.typeoutro-
dc.contributor.institutionUniversidade Nove de Julho (UNINOVE)-
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)-
dc.contributor.institutionUniv British Columbia-
dc.description.affiliationUNINOVE Nove de Julho Univ, Sleep Lab, Sao Paulo, Brazil-
dc.description.affiliationUNESP Dent Sch, Sao Jose Dos Campos, Brazil-
dc.description.affiliationUniv British Columbia, Vancouver, BC V5Z 1M9, Canada-
dc.description.affiliationUnespUNESP Dent Sch, Sao Jose Dos Campos, Brazil-
dc.identifier.doi10.11607/ijp.3284-
dc.identifier.wosWOS:000321882500006-
dc.rights.accessRightsAcesso restrito-
dc.relation.ispartofInternational Journal of Prosthodontics-
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.